Latest Insider Transactions at Atara Biotherapeutics, Inc. (ATRA)
This section provides a real-time view of insider transactions for Atara Biotherapeutics, Inc. (ATRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Atara Biotherapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Atara Biotherapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2024
|
Anh Co Nguyen President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+36.26%
|
-
|
|
Aug 16
2024
|
Jill Henrich EVP, Global Head RA & Quality |
SELL
Open market or private sale
|
Direct |
963
-2.27%
|
$5,778
$6.63 P/Share
|
|
Aug 16
2024
|
Eric J Hyllengren EVP, CFO |
SELL
Open market or private sale
|
Direct |
1,070
-2.07%
|
$6,420
$6.63 P/Share
|
|
Aug 16
2024
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,158
-1.39%
|
$6,948
$6.63 P/Share
|
|
Aug 16
2024
|
Anh Co Nguyen President and CEO |
SELL
Open market or private sale
|
Direct |
1,821
-1.7%
|
$10,926
$6.63 P/Share
|
|
Aug 16
2024
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
3,038
-2.08%
|
$18,228
$6.63 P/Share
|
|
May 16
2024
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
81,506
-4.27%
|
$0
$0.62 P/Share
|
|
May 16
2024
|
Jill Henrich EVP, Global Head RA & Quality |
SELL
Open market or private sale
|
Direct |
25,750
-4.64%
|
$0
$0.62 P/Share
|
|
May 16
2024
|
Eric J Hyllengren EVP, CFO |
SELL
Open market or private sale
|
Direct |
28,648
-4.25%
|
$0
$0.62 P/Share
|
|
May 16
2024
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
32,401
-4.45%
|
$0
$0.62 P/Share
|
|
May 16
2024
|
Anh Co Nguyen President and CEO |
SELL
Open market or private sale
|
Direct |
42,899
-4.56%
|
$0
$0.62 P/Share
|
|
Mar 31
2024
|
Ameet Mallik |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+39.74%
|
-
|
|
Mar 31
2024
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+19.24%
|
-
|
|
Mar 31
2024
|
Maria Grazia Roncarolo |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+38.61%
|
-
|
|
Mar 31
2024
|
William K Heiden |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+29.47%
|
-
|
|
Mar 31
2024
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+36.67%
|
-
|
|
Mar 04
2024
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,044
-1.36%
|
$0
$0.72 P/Share
|
|
Mar 04
2024
|
Anh Co Nguyen President and CEO |
SELL
Open market or private sale
|
Direct |
10,746
-1.13%
|
$0
$0.72 P/Share
|
|
Mar 04
2024
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
24,844
-1.28%
|
$0
$0.72 P/Share
|
|
Mar 04
2024
|
Jill Henrich EVP, Global Head RA & Quality |
SELL
Open market or private sale
|
Direct |
3,879
-0.69%
|
$0
$0.72 P/Share
|
|
Mar 04
2024
|
Eric J Hyllengren EVP, CFO |
SELL
Open market or private sale
|
Direct |
6,679
-0.49%
|
$0
$0.72 P/Share
|
|
Jan 08
2024
|
Jill Henrich EVP, Global Head RA & Quality |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+44.6%
|
-
|
|
Jan 08
2024
|
Eric J Hyllengren EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
475,000
+41.09%
|
-
|
|
Jan 08
2024
|
Amar Murugan EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
475,000
+39.17%
|
-
|
|
Jan 08
2024
|
Anh Co Nguyen President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
675,000
+41.48%
|
-
|
|
Jan 08
2024
|
Pascal Touchon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,280,000
+39.81%
|
-
|
|
Nov 16
2023
|
Manher Joshi EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,287
-6.69%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,307
-3.13%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Anh Co Nguyen President and CEO |
SELL
Open market or private sale
|
Direct |
8,856
-3.1%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
20,409
-3.02%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Jill Henrich EVP, Global Head RA & Quality |
SELL
Open market or private sale
|
Direct |
3,267
-3.03%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Eric J Hyllengren EVP, CFO |
SELL
Open market or private sale
|
Direct |
11,958
-5.49%
|
$0
$0.39 P/Share
|
|
Nov 14
2023
|
Carol Giltner Gallagher |
BUY
Open market or private purchase
|
Direct |
90,980
+16.53%
|
$0
$0.31 P/Share
|
|
Nov 13
2023
|
Carol Giltner Gallagher |
BUY
Open market or private purchase
|
Direct |
179,020
+32.7%
|
$0
$0.22 P/Share
|
|
Nov 10
2023
|
Eric Dobmeier |
BUY
Open market or private purchase
|
Direct |
446,825
+44.23%
|
$0
$0.23 P/Share
|
|
Nov 10
2023
|
William K Heiden |
BUY
Open market or private purchase
|
Direct |
100,000
+32.36%
|
$0
$0.25 P/Share
|
|
Aug 16
2023
|
Jill Henrich EVP, Global Head RA & Quality |
SELL
Open market or private sale
|
Direct |
3,346
-1.51%
|
$3,346
$1.65 P/Share
|
|
Aug 16
2023
|
Manher Joshi EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,975
-1.85%
|
$6,975
$1.65 P/Share
|
|
Aug 16
2023
|
Anh Co Nguyen President and CEO |
SELL
Open market or private sale
|
Direct |
15,126
-2.54%
|
$15,126
$1.65 P/Share
|
|
Aug 16
2023
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
30,766
-2.2%
|
$30,766
$1.65 P/Share
|
|
Aug 16
2023
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,672
-1.59%
|
$8,672
$1.65 P/Share
|
|
Aug 16
2023
|
Eric J Hyllengren EVP, CFO |
SELL
Open market or private sale
|
Direct |
8,186
-1.82%
|
$8,186
$1.65 P/Share
|
|
Jun 27
2023
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
14,291
-1.98%
|
$14,291
$1.66 P/Share
|
|
May 31
2023
|
Beth C Seidenberg |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+33.01%
|
-
|
|
May 31
2023
|
William K Heiden |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+34.34%
|
-
|
|
May 31
2023
|
Eric Dobmeier |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+32.85%
|
-
|
|
May 31
2023
|
Ameet Mallik |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+42.38%
|
-
|
|
May 31
2023
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+34.34%
|
-
|
|
May 31
2023
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+23.13%
|
-
|
|
May 31
2023
|
Maria Grazia Roncarolo |
BUY
Grant, award, or other acquisition
|
Direct |
57,000
+39.18%
|
-
|